Walgreens Nears $10 Billion Deal to Go Private

The drugstore chain is in advanced talks with Sycamore Partners to finalize a buyout that could reshape its business strategy.

Boots Alliance is close to finalizing a $10 billion deal with private equity firm Sycamore Partners to take the company private.
Sycamore Partners is expected to pay between $11.30 and $11.40 per share in cash, with potential contingent value rights tied to financial performance.
If the deal proceeds, Sycamore plans to retain Walgreens' U.S. retail pharmacy business while potentially selling or taking public other segments like Boots in the UK.
Walgreens has faced significant financial challenges, including declining market value, store closures, and legal issues related to the opioid crisis.
The transaction, which follows months of negotiations, could be completed as soon as Thursday, barring any last-minute obstacles.